Loading...
XSTO
BOUL
Market cap9mUSD
Oct 09, Last price  
2.42SEK
1D
2.98%
1Q
-36.48%
Jan 2017
-96.54%
IPO
-79.05%
Name

Boule Diagnostics AB

Chart & performance

D1W1MN
XSTO:BOUL chart
P/E
—
P/S
0.19
EPS
—
Div yield, %
—
Shrs. gr., 5y
6.74%
Rev. gr., 5y
4.11%
Revenues
490m
-12.33%
168,693,500175,391,166229,421,000246,155,000275,301,000276,804,000306,687,000331,407,000400,735,000427,793,000424,400,000498,916,000400,458,000463,344,000548,088,000571,329,000558,600,000489,700,000
Net income
-4m
L-98.30%
-5,549,061-10,548,23318,891,00011,711,00010,959,000-70,125,00030,265,00015,352,00036,033,00037,239,00041,031,00037,548,000-47,965,00023,272,00012,728,00024,977,000-223,300,000-3,800,000
CFO
829k
-98.22%
4,310,8948,203,59716,159,0005,444,00010,948,00015,675,00030,985,00022,324,00019,875,00057,715,00022,663,00053,976,00075,239,00043,284,000-11,353,00051,377,00046,600,000829,000
Dividend
May 06, 20220.55 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.

Related entities

Subsidiaries
Boule Medical AB

Key people

President, Chief Executive Officer · since 2020
Fredrik Ekdahl
Senior Vice President Research & Development · since 2017
Michael Elliott
Senior Vice President Research & Development at CDS
Debbie Herrera
Senior Vice President of Quality & Regulatory · since 2017
Hans Johansson
Senior Vice President of Production
Chief Financial Officer, Senior Vice President · since 2017
Kiarash Farr
Director of Commercial Operations · since 2018
Director · since 2014
Director · since 2018
Karin Dahllof
Independent Director · since 2015
Independent Director · since 2016
IPO date
Jun 23, 2011
Employees
200
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Fagerstagatan 7
SPÅNGA 163 53
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT